Evidence map›Paper›PMID 30124919›Full record

ArticleOperative neurosurgery (Hagerstown, Md.)2019

Near-Infrared Optical Contrast of Skull Base Tumors During Endoscopic Endonasal Surgery.

Jun W Jeon, Steve S Cho, Shayoni Nag, Love Buch, John Pierce, YouRong S Su, Nithin D Adappa, James N Palmer, Jason G Newman, Sunil Singhal and 1 more

Open access · greenAbstract read
In one paragraph

Article in Operative neurosurgery (Hagerstown, Md.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Guidelines in the management of CNS tumors.Journal of neuro-oncology · 2021
    Guideline
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Fluorophores in Endoscopic Neurosurgery.Advances and technical standards in neurosurgery · 2024
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Jun W JeonDepartment of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Steve S ChoDepartment of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Shayoni NagDepartment of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Love BuchDepartment of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
John PierceDepartment of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
YouRong S SuDepartment of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Nithin D AdappaDepartment of Otorhinolaryngology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
James N PalmerDepartment of Otorhinolaryngology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Jason G NewmanDepartment of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Sunil SinghalDepartment of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
John Y K LeeDepartment of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Hospital of the University of Pennsylvania · US

Funding

Phenotypic Diversity in COVID-19UL1TR001878 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2016 to 2025
$102.4M
NCATS NIH HHS UL1 TR001878
6 · The paper itself

Abstract

backgroundNear-infrared (NIR) tumor contrast is achieved through the "second-window ICG" technique, which relies on passive accumulation of high doses of indocyanine green (ICG) in neoplasms via the enhanced permeability and retention effect.

objectiveTo report early results and potential challenges associated with the application of second-window ICG technique in endonasal endoscopic, ventral skull-base surgery, and to determine potential predictors of NIR signal-to-background ratio (SBR) using endoscopic techniques.

methodsPituitary adenoma (n = 8), craniopharyngioma (n = 3), and chordoma (n = 4) patients received systemic infusions of ICG (5 mg/kg) approximately 24 h before surgery. Dual-channel endoscopy with visible light and NIR overlay were photodocumented and analyzed post hoc.

resultsAll tumors (adenoma, craniopharyngioma, chordoma) demonstrated NIR positivity and fluoresced with an average SBR of 3.9 ± 0.8, 4.1 ± 1.7, and 2.1 ± 0.6, respectively. Contrast-enhanced T1 signal intensity proved to be the single best predictor of observed SBR (P = .0003). For pituitary adenomas, the sensitivity, specificity, positive predictive value, and negative predictive value of NIR-guided identification of tumor was 100%, 20%, 71%, and 100%, respectively.

conclusionIn this preliminary study of a small set of patients, we demonstrate that second-window ICG can provide NIR optical tumor contrast in 3 types of ventral skull-base tumors. Chordomas demonstrated the weakest NIR signal, suggesting limited utility in those patients. Both nonfunctional and functional pituitary adenomas appear to accumulate ICG, but utility for margin detection for the adenomas is limited by low specificity. Craniopharyngiomas with third ventricular extension appear to be a particularly promising target given the clean brain parenchyma background and strong SBR.

Indexed as

AdenomaAdultAgedAged, 80 and overChordomaCraniopharyngiomaFemaleHumansMaleMiddle AgedMonitoring, IntraoperativeNeuroendoscopyOptical ImagingPituitary NeoplasmsSkull Base NeoplasmsTreatment OutcomeBrain tumorEndoscopyFluorescenceIndocyanine greenNear-infrared

Identifiers

PMID30124919
PMCPMC7311828
OpenAlexW2885418151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.